Search Results For :: healthcare crm

• Healthcare Cloud Computing Market by Product (EHR, VNA, RIS, LIS, RCM), Deployment (Private, Public), Component (Software, Service), Pricing (Spot), Service Model (SaaS, IaaS, PaaS), End User (Provider (Hospital), Payer) - Global Forecast to 2029

  The global healthcare cloud computing market, valued at US$46.1B in 2023, is forecasted to grow at a 17.5% CAGR, reaching US$53.8B by 2024 and US$120.6B by 2029. The market growth is fueled by several factors, including the increased adoption of EHR, e-prescribing, telehealth, mHealth, and other healthcare IT solutions; the rising use of big data analytics, wearable devices, and IoT; the growing implementation of cloud deployment in the healthcare sector; the enhanced data storage, flexibility, and scalability provided by cloud computing; the emergence of new payment models and the cost-efficiency of cloud solutions; and the evolving nature of health benefit plan designs.

  • Published: May 2024
  • Price: $ 4950
  • TOC Available:

• A2P Messaging Market by Application (Authentication Services, Promotional & Marketing Services, Customer Relationship Management Services, Pushed Content Services, Interactive Messaging Services, Notification & Alerts) - Global Forecast to 2029

  MarketsandMarkets forecasts that the A2P messaging market size is projected to reach USD 84.8 billion by 2029, at a CAGR of 3.0% during the forecast period. The A2P messaging market comprises major providers, such as AT&T (US), China Mobile (China), Sinch (Sweden), Twilio (US), Infobip (UK), Vonage (US), Orange (France), Comviva (India), Route Mobile (India), BICS (Belgium), Monty Mobile (UK), Tata Communications (India), Syniverse (US), Tyntec (UK), Soprano Design (Australia), Genesys (US), Clickatell (US), CEQUENS (Egypt), MSG91 (India), Plivo (US), Mitto (Switzerland), Bird (Netherlands), Telewhale (Cyprus), EnableX.io (Singapore), TextUs (US), Voxvalley (Singapore). To increase their market share in the A2P messaging industry, these competitors have used a variety of growth methods, including partnerships, agreements, collaborations, new product releases, product enhancements, and acquisitions.

  • Published: May 2024
  • Price: $ 4950
  • TOC Available:

• Active Pharmaceutical Ingredient Market by Type (Innovative, Generic), Manufacturer (captive, merchant), Synthesis (Synthetic, Biotech), Products (mAb, Hormones, Cytokines), Drug (OTC, Rx), Application (Diabetes, oncology, CVD) - Global Forecast to 2029

  The global active pharmaceutical ingredient market, valued at US$158.1B in 2023, is forecasted to grow at a 7.8% CAGR, reaching US$163.5B by 2024 and US$238.3B by 2029. The major factors driving the growth of this market include the increasing R&D funding, increasing outsourcing of active pharmaceutical ingredients manufacturing services, increase in healthcare expenditure.

  • Published: May 2024
  • Price: $ 4950
  • TOC Available:

• Cardiac Monitoring & Cardiac Rhythm Management Devices Market by Monitoring (ECG (Holter, ILR), COM), Rhythm Management (Defibrillators (ICD, AED), Pacemaker), Application (Heart Failure, Arrhythmias, MI), Procedure (Invasive) & Region - Global Forecast to 2029

  The global cardiac monitoring & cardiac rhythm management devices market, valued at US$20.7B in 2023, is forecasted to grow at a 4.3% CAGR, reaching US$21.3B by 2024 and US$26.4B by 2029. Market growth in the Asia Pacific can be attributed to the increasing adoption of sedentary lifestyles, changing diets, increasing stress, and habitual smoking and drinking, and rising morbidity and mortality from CVD.

  • Published: May 2024
  • Price: $ 4950
  • TOC Available:

• Wireless Broadband in Public Safety Market by Technology (Mobile Wireless Broadband, Fixed Wireless Broadband, Satellite Wireless Broadband), Application (Critical Communication, Geographic Information System) - Global Forecast to 2029

  The wireless broadband in public safety market size is projected to reach USD 126.9 billion by 2029, at a Compound Annual Growth Rate (CAGR) of 25.9% during the forecast period. The major vendors covered in the wireless broadband in public safety market are AT&T(US), Verizon Communications Inc (US), Cisco Systems, Inc (US), Ericsson (Sweden), Huawei Technologies Co. Ltd (China), Broadcom (US), HPE Aruba Networks (US), Extreme Networks (US), Juniper Networks (US), Motorola Solutions (US), NEC Corporation (Japan), Netgear, Inc (US), Semtech Corporation (US), ZTE Corporation (China), General Dynamics Corporation (US), L3Harris Technologies, Inc (US), Bittium Corporation (Finland), Hughes Network Systems, LLC (US), Hytera Communications Corporation (China), Cambium Networks Limited (US), Infinet Wireless (Netherlands), Netronics Networks (Canada), Proxim Wireless (US), Radwin (Israel), Aviat Networks, Inc (US), Knightscope (US), Parallel Wireless (US). These players have adopted various growth strategies, such as partnerships, agreements and collaborations, new product launches, enhancements, and acquisitions to expand their footprint in the wireless broadband in public safety market.

  • Published: April 2024
  • Price: $ 4950
  • TOC Available:

• Probiotics Market Size, Share, Analysis, & Growth Trends Report by Product Type (Functional Food & Beverages (FnB), Dietary Supplements, and Feed), Ingredient (Bacteria and Yeast), End User (Human and Animal), Distribution Channel and Region - Global Forecast to 2029

  According to MarketsandMarkets, the global Probiotics market size is projected to reach USD 105.7 billion by 2029, recording a CAGR of 8.2% during the forecast period. Key players in this market include Probi (Sweden), Nestlé (Switzerland), ADM (US), Danone (France), International Flavors & Fragrances Inc. (US), Yakult Honsha Co., Ltd. (Japan), BioGaia (Sweden), MORINAGA MILK INDUSTRY CO., LTD. (Japan), Meiji Holdings Co., Ltd. (Japan), Lifeway Foods, Inc. (US), Adisseo (France), Winclove Probiotics (US), AB-Biotics, S.A. (Belgium), Apsen Farmacêutica (Brazil), and Lallemand (Canada).

  • Published: March 2024
  • Price: $ 4950
  • TOC Available:

• Stem Cell Therapy Market by Type (Allogeneic, Autologous), Cell Source (Adipose Tissue, Bone Marrow, Placenta/Umbilical Cord), Therapeutic Application (Musculoskeletal, Wounds, Surgeries, Inflammatory, Autoimmune, Cardiovascular) & Region - Global Forecast to 2028

  The global stem cell therapy market, valued at US$259M in 2022, is forecasted to grow at a 16.5% CAGR, reaching US$286M by 2023 and US$615M by 2028. Market growth is driven mainly by factors such as rise in funding for stem cell research, upsurge in the number of cell therapy production facilities that have GMP certification, and increased in the number of clinical trials associated with stem cell therapies.

  • Published: December 2023
  • Price: $ 4950
  • TOC Available:

• Diagnostic Imaging Market Size, Share & Trends by Product (MRI (Open, Closed), Ultrasound (2D, 4D, Doppler), X-Ray (Digital, Analog), CT, SPECT, Hybrid PET, Mammography), Application (Ob/GYN, CVDs, Brain, Cancer), End User (Hospitals, Clinics), & Region - Global Forecast to 2028

  The global diagnostic imaging market, valued at $26.5 billion in 2023, is expected to grow to $34.6 billion by 2028, with a CAGR of 5.5%. Growth drivers include an aging population and increasing chronic diseases, supported by rising grants, teleradiology adoption, and technological advancements. Challenges include high system costs and a shortage of trained professionals. Emerging economies present growth opportunities due to increasing disease prevalence and supportive government policies. Key market players are GE Healthcare, Siemens Healthineers, and Philips, with North America currently leading the market.

  • Published: September 2023
  • Price: $ 4950
  • TOC Available:

• Biosimilars Market by Drug Class (Drug Class (Monoclonal Antibodies (Adalimumab, Infliximab, Rituximab, Trastuzumab), Insulin, Erythropoietin, Anticoagulants. rhGH), Indication, Region – Global Forecast to 2028

  Biosimilars market growth is primed to transition from 29.4 billion in 2023 to USD 66.9 billion by 2028, showcasing a strong CAGR of 17.8%. This market is driven by increasing demand for cost-effective treatments amidst rising chronic disease rates and the patent expirations of major biologics. Key trends include the rapid approval and adoption of biosimilars, particularly in oncology.

  • Published: June 2023
  • Price: $ 4950
  • TOC Available:

• Life Science Instrumentation Market by Technology (Spectroscopy, Chromatography, Immunoassay, NGS, PCR, Microscopy), Application (Diagnostic, Clinical), End User (Pharma, Agriculture & Food Industry, Hospitals, Diagnostic Labs) & Region - Global Forecast to 2028

  The global life science instrumentation market, valued at US$50.9B in 2022, is forecasted to grow at a 6.1% CAGR, reaching US$54.9B by 2023 and US$73.9B by 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.

  • Published: May 2023
  • Price: $ 4950
  • TOC Available:

• FIRST
• PREVIOUS
• NEXT
• LAST

Records 31 to 40 of 64